Tag Archives: Atreca Inc.

Investors shell out $619M in huge health-sector IPO stampede.

The News: Four biotechs and a genome-sequencing player firm grabbed their brass rings last week, cashing in with $619 million in total IPO funding. That means that with one week… Read more »